Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
Demystifying clinical data for treating invasive AmpC-harboring Enterobacterales.
A food for thought as an ambulatory antibiotic stewardship initiative.
This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.
Scott Bertani, who is the director of Advocacy of the National Coalition for LGBTQ Health, discusses what the new mpox health declarations mean to the US, which groups are high risk, and information about the vaccine to prevent the disease.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Hepatitis B virus vaccination shown to to significantly improve survival rates for patients with chronic hepatitis C, nonalcoholic liver disease, and liver cirrhosis.
Unique challenges can affect the success of the shift from pediatric to adult care settings.
To close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Christine Slover, PharmD discussed cefiderocol's effectiveness against challenging infections, including those caused by multi-drug resistant bacteria.
Su H Wang, MD, FACP, MPH discusses combating vaccine misinformation, preventing outbreaks, and highlighting global health interconnectedness
Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.
With the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Cornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.
Important clinical considerations to know about resistant CMV infections.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
New therapeutics offer some hope in this emerging market.
The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.
Clinicians review a patient case including diagnosis, treatment, and follow-up.
The prevalence of this disease in this patient population is much higher than in the general public.